Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis

Research in Microbiology

Volumn 158, Issue 7, 2007, Pages 625-630

  Varella Coelho, Marcus Lívio ^a   Santos Nascimento, Janaína dos ^a   Fagundes, Patrícia Carlin ^a   Madureira, Danielle Jannuzzi ^a   Oliveira, Selma Soares de ^a   Vasconcelos de Paiva Brito, Maria Aparecida ^b   Freire Bastos, Maria do Carmo de ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b EMBRAPA CERRADOS   (Brazil)

Author keywords

Antimicrobial peptides; Aureocins; Bacteriocins; Bovine mastitis; Staphylococcins; Staphylococcus aureus; Streptococcus agalactiae

Indexed keywords

AUREOCIN 215FN; AUREOCIN A53; AUREOCIN A70; BACTERIOCIN; EPICIDIN 280; EPIDERMIN; EPILANCIN K7; PROTEIN PEP5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CATTLE; CATTLE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE;

BOVINAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE;

EID: 34748848577     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2007.07.002     Document Type: Article

References (30)

1. Araújo S.A., and Bastos M.C.F. Incompatibility and molecular relationships between small bacteriocinogenic plasmids of Staphylococcus aureus. World J. Microbiol. Biotechnol 11 (1995) 525-528
2. Augustin J., Rosenstein R., Wieland B., Schneider U., Schnell N., Engelke G., Entian K.D., and Gotz F. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem 204 (1992) 1149-1154
3. Bannerman T.L. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 8th Edition (2003), ASM Press, Washington, DC 384-404
4. Barkema H.W., Schukken Y.H., and Zadocks R.N. The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 89 (2006) 1877-1895
5. Berry E.A., and Hillerton J.E. The effect of selective dry cow treatment on new intramammary infections. J. Dairy Sci. 85 (2002) 112-121
6. Bradley A.J. Bovine mastitis: an evolving disease. Vet. J. 164 (2002) 116-128
7. Cotter P.D., Hill C., and Ross R.P. Bacteriocins: developing innate immunity for food. Nat. Rev. 3 (2005) 777-788
8. Crandall A.D., and Montville T. Nisin resistance in Listeria monocytogenes ATCC 700302 is a complex phenotype. Appl. Environ. Microbiol. 64 (1998) 231-237
9. Dingwell R.T., Duffield T.F., Leslie K.E., Keefe G.P., DesCoteaux L., Kelton D.F., Lissemore K.D., Schukken Y.H., Dick P., and Bagg R. The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period. J. Dairy Sci. 85 (2002) 3250-3259
10. Ennahar S., Sashihara T., Sonomoto K., and Ishizaki A. Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol. Rev. 24 (2000) 85-106
11. Giambiagi-deMarval M., Mafra M.A., Penido E.G.C., and Bastos M.C.F. Distinct groups of plasmids correlated with bacteriocin production in Staphylococcus aureus. J. Gen. Microbiol. 136 (1990) 1591-1599
12. Green M.J., Green L.E., Medley G.F., Schukken Y.H., and Bradley A.J. Influence of dry period bacterial intramammary infection on clinical mastitis in dairy cows. J. Dairy Sci. 85 (2002) 2589-2599
13. Gruet P., Maincent P., Berthelot X., and Kaltsatos V. Bovine mastitis and intramammary drug delivery: review and perspectives. Adv. Drug Deliv. Rev. 50 (2001) 245-259
14. Heidrich C., Pag U., Josten M., Metzger J., Jack R.W., Bierbaum G., Jung G., and Sahl H.-G. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl. Environ. Microbiol. 64 (1998) 3140-3146
15. Jack R.W., Tagg J.R., and Ray B. Bacteriocins of Gram-positive bacteria. Bacteriol. Rev. 59 (1995) 171-200
16. Kaletta C., Entian K.-D., Kellner R., Jung G., Reis M., and Sahl H.-G. Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch. Microbiol. 152 (1989) 16-19
17. Limonet M., Revol-Junelles A.M., and Milliere J.B. Variation in the membrane fatty acid composition of resistant or susceptible Leuconostoc or Weissella strains in the presence or absence of mesenterocin 52A and mesenterocin 52B produced by Leuconostoc mesenteroides subsp. mesenteroides FR2. Appl. Environ. Microbiol. 68 (2002) 2910-2916
18. Lüders T., Kirkemo G.A., Fimland G., Nissen-Meyer J., and Nes I.F. Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria. Appl. Environ. Microbiol. 69 (2003) 1797-1799
19. McAuliffe O., Ross R.P., and Hill C. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25 (2001) 285-308
20. Meaney B., Ryan M.P., Flynn J., Hill C., and Ross R.P. The use of a non-antibiotic teat sealer in combination with a food-grade bacteriocin, lacticin 3147, for mastitis prevention in non lactating dairy cows. Cattle Practice 7 (1999) 215-219
21. Nascimento J.S., Abrantes A., Giambiagi-deMarval M., and Bastos M.C.F. Growth conditions required for bacteriocin production by strains of Staphylococcus aureus. World J. Microbiol. Biotechnol. 20 (2004) 941-947
22. Nascimento J.S., Ceotto H., Nascimento S.B., Giambiagi-deMarval M., Santos K.R.N., and Bastos M.C.F. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Lett. Appl. Microbiol. 42 (2006) 215-221
23. Netz D.J.A., Sahl H.-G., Marcolino R., Nascimento J.S., Oliveira S.S., Soares M.B., and Bastos M.C.F. Molecular characterisation of aureocin A70, a multipeptide bacteriocin isolated from Staphylococcus aureus. J. Mol. Biol. 311 (2001) 939-949
24. Netz D.J.A., Pohl R., Beck-Sickinger A.G., Selmer T., Pierik A.J., Bastos M.C.F., and Sahl H.-G. Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J. Mol. Biol. 319 (2002) 745-756
25. Oliveira S.S., Póvoa D.C., Nascimento J.S., Pereira M.S.V., Siqueira Jr. J.P., and Bastos M.C.F. Antimicrobial substances produced by Staphylococcus aureus strains isolated from cattle in Brazil. Lett. Appl. Microbiol. 27 (1998) 229-234
26. Oliveira S.S., Abrantes J., Cardoso M., Sordelli D., and Bastos M.C.F. Staphylococcal strains involved in bovine mastitis are inhibited by Staphylococcus aureus antimicrobial peptides. Lett. Appl. Microbiol. 27 (1998) 287-291
27. Pinón D., Casas M., Blanch M., Fontaniella B., Bianco Y., Vicente C., Solas M.T., and Legaz M.E. Glucanobacter diazotrophicus, a sugar cane endosymbiont, produces a bacteriocin against Xanthomonas albilineans, a sugar cane pathogen. Res. Microbiol. 153 (2002) 345-351
28. Ryan M.P., Meaney W.J., Ross R.P., and Hill C. Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Appl. Environ. Microbiol. 64 (1998) 2287-2290
29. Sahl H.-G., and Bierbaum G. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria. Annu. Rev. Microbiol. 52 (1998) 41-79
30. van de Kamp M., Horstink L.M., van den Hooven H.W., Konings R.N., Hilbers C.W., Frey A., Sahl H.-G., Metzger J.W., and van de Vem F.J. Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur. J. Biochem 227 (1995) 757-771